Floatz logo

Vinorelbine

Prostate Cancer Metastatic

Beth Israel Deaconess Medical CenterPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
81/ 100

Competitive context

25 Active assets in the Prostate Cancer Metastatic cohort.

Asset / SponsorPhaseRating
Pembrolizumab
CuraCell TX AB
Phase 2BB
Epirubicin
CuraCell TX AB
Phase 2BB
CABAZITAXEL
Sanofi
Phase 4BB
Rosuvastatin
National Cancer Institute, Egypt
Phase 4BB
Osteodex
DexTech Medical AB
Phase 2B

View all 50 →

Same molecule, other indications

Vinorelbine is also rated in:

HER2 positive breast carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →
Recurrent Breast CarcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →